Ironstone Product Development (IPD) acquired by global medtech leader, Avania

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Ironstone Product Development has recently joined Avania, a leading, global full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics and device-drug combination products internationally.

Ironstone is an alumnus of our EAHN™ program.

Arsheen Kaur
Previous

Specific Biologics announces additional investment and appointment of experienced biotechnology leader to the Board of Directors
Next

Innovation Factory expands support for high-potential life science innovators by introducing medtech manufacturing funding program